Alamak Biosciences Patents – Insights & Stats (Updated 2024)

Alamak Biosciences has a total of 11 patents globally, out of which 11 have been granted. Of these 11 patents, more than 91% patents are active. United States of America is where Alamak Biosciences has filed the maximum number of patents. Parallelly, USA seems to be the main focused R&D center and is also the origin country of Alamak Biosciences.

Alamak Biosciences, based in Massachusetts and founded in 2011, has been serving the pharmaceutical industry for over 12 years. They specialize in tissue-based tests, mainly supporting gene therapy projects. Their services include antibody testing, eye models for research, brain models for gene therapy using primates and rodents, and studies related to neuroscience. They are also skilled in identifying specific brain regions for bio-distribution studies.

Do read about some of the most popular patents of Alamak Biosciences which have been covered by us in this article and also you can find Alamak Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Alamak Biosciences patent portfolio.

How many patents does Alamak Biosciences have?

Alamak Biosciences has a total of 11 patents globally. These patents belong to 3 unique patent families. Out of 11 patents, 10 patents are active.

How Many Patents did Alamak Biosciences File Every Year?

Alamak Biosciences Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAlamak Biosciences Applications FiledAlamak Biosciences Patents Granted
20192
20186
201631
201552
20133

How many Alamak Biosciences patents are Alive/Dead?

How Many Patents did Alamak Biosciences File in Different Countries?

All the Patents were filed by Alamak Biosciences in the United States of America.

Where are Research Centers of Alamak Biosciences Patents Located?

The Research Centre for all the Alamak Biosciences patents is the United States of America.

Best Patents Of Alamak Biosciences

US9395283B1 is the most popular patent in the Alamak Biosciences portfolio. It has received 19 citations so far from company like Roche.

Below is the list of most cited patents of Alamak Biosciences:

Publication NumberCitation Count
US9395283B119
USD734483S16
USD739549S15
USD815750S11

List of Alamak Biosciences Patents


Alamak Biosciences PatentsTitle
US10197479B1In Vitro Homogenous Dna And Rna Cell Blocks Made Using A Multi-Chambered Rotating Apparatus
US10197569B1In Vitro Homogenous Cell Block, Method Of Making And Using
US10132729B1In Vitro Homogenous Cell Block, Method Of Making And Using
USD815296S1Tissue Cell Block
USD815297S1Tissue Cell Block
USD815748S1Tissue Cell Block
USD815749S1Tissue Cell Block
USD815750S1Tissue Cell Block
US9395283B1In Vitro Homogenous Cell Block, Method Of Making And Using
USD734483S1Tissue Cell Block For Cancer Detection
USD739549S1Tissue Cell Block

What are Alamak Biosciences key innovation segments?

What Technologies are Covered by Alamak Biosciences?

The chart below distributes patents filed by Alamak Biosciences in different countries on the basis of the technology protected in patents. It also represents the markets where Ophthalmic Sciences thinks it’s important to protect particular technology inventions.

R&D Focus: How has Alamak Biosciences search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Alamak Biosciences?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.